Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper from tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper from tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
The Psoriasis Epidemiology Screening Tool (PEST) can help identify patients with psoriasis at higher risk of developing psoriatic arthritis. Do you know the key indicator? Take our quiz to find out!
The Psoriasis Epidemiology Screening Tool (PEST) can help identify patients with psoriasis at higher risk of developing psoriatic arthritis. Do you know the key indicator? Take our quiz to find out!
Research found older age, historical fracture, and opioid use to be associated with higher odds of fracture in Medicare beneficiaries with ankylosing spondylitis.
Research found older age, historical fracture, and opioid use to be associated with higher odds of fracture in Medicare beneficiaries with ankylosing spondylitis.
Researchers found some key factors responsible for higher odds of fracture among older patients with ankylosing spondylitis. Take our quiz to test your knowledge!
Researchers found some key factors responsible for higher odds of fracture among older patients with ankylosing spondylitis. Take our quiz to test your knowledge!
Dr Paras Karmacharya discusses the findings of the PsA Research Consortium (PARC) cohort study that underscores the need for personalized treatment approaches in psoriatic arthritis, accounting for unique disease features.
Dr Paras Karmacharya discusses the findings of the PsA Research Consortium (PARC) cohort study that underscores the need for personalized treatment approaches in psoriatic arthritis, accounting for unique disease features.
